メタ情報
| meta description平均長 | 90.92 |
|---|
| OGPありページ数 | 0 |
|---|
| Twitterカードありページ数 | 0 |
|---|
内部リンク分析(Internal)
| ユニーク内部リンク数 | 24 |
|---|
| ページあたり内部リンク平均 | 24.58 |
|---|
連絡先候補(Contacts)
このデータの閲覧には会員登録が必要になります。会員登録
キーワード分析(KeywordMap)
ワードクラウド上位
| 語 | 重み |
|---|
| Novaferon | 1 |
| protein | 0.775 |
| customer | 0.678558 |
| information | 0.678558 |
| antiviral | 0.662476 |
| personal | 0.565465 |
| molecules | 0.504744 |
| novel | 0.504744 |
| development | 0.441651 |
| DNA | 0.407732 |
| effects | 0.395825 |
| production | 0.378558 |
| proteins | 0.378558 |
| Nova | 0.378521 |
| CSF | 0.375 |
| clinical | 0.366959 |
| Genova | 0.355696 |
| proprietary | 0.35 |
| engineering | 0.35 |
| viral | 0.35 |
| new | 0.347011 |
| cellular | 0.339279 |
| respiratory | 0.339279 |
| patients | 0.339279 |
| cells | 0.326186 |
| our | 0.326186 |
| EPO | 0.325 |
| drugs | 0.315465 |
| human | 0.3 |
| interferon | 0.285413 |
| center | 0.282732 |
| facility | 0.282732 |
| collected | 0.282732 |
| Google | 0.282732 |
| only | 0.282732 |
| can | 0.282732 |
| SARS | 0.282732 |
| CoV | 0.282732 |
| immunity | 0.282732 |
| COVID | 0.275 |
| research | 0.275 |
| blood | 0.252372 |
| half | 0.252372 |
| life | 0.252372 |
| against | 0.252372 |
| potency | 0.25 |
| has | 0.25 |
| two | 0.244639 |
| sequences | 0.244639 |
| technical | 0.226186 |
共起語上位
| 語1 | 語2 | スコア | 共起ページ数 |
|---|
| inquiries | please | 3.554441 | 48 |
| inquiries | questions | 3.424559 | 48 |
| any | questions | 3.263163 | 48 |
| email | please | 3.262185 | 36 |
| email | inquiries | 3.150334 | 36 |
| half | life | 3.117996 | 32 |
| information | personal | 3.114927 | 40 |
| EPO | Nova | 3.038374 | 45 |
| blood | half | 3.0181 | 32 |
| お問い合わせフォーム | ご質問やご相談はメール | 2.917892 | 24 |
| お問い合わせフォーム | でお問い合わせください | 2.893149 | 24 |
| please | questions | 2.801601 | 36 |
| email | inquiry | 2.784823 | 24 |
| broad | spectrum | 2.74867 | 20 |
| have | you | 2.722364 | 48 |
| CoV | SARS | 2.692898 | 18 |
| CSF | EPO | 2.645644 | 39 |
| any | have | 2.62854 | 48 |
| high | potency | 2.626374 | 28 |
| blood | prolonged | 2.597217 | 24 |
| human | interferon | 2.587773 | 28 |
| Biotech | Ltd | 2.570652 | 16 |
| acting | long | 2.570652 | 16 |
| America | North | 2.570652 | 16 |
| any | inquiries | 2.55076 | 36 |
| inquiry | please | 2.502534 | 24 |
| any | you | 2.492569 | 36 |
| CSF | Nova | 2.425118 | 36 |
| inquiries | inquiry | 2.411993 | 24 |
| blood | life | 2.387249 | 24 |
| processes | production | 2.370505 | 22 |
| molecules | protein | 2.361638 | 51 |
| you | でお問い合わせください | 2.340145 | 24 |
| platform | technologies | 2.332107 | 16 |
| ご質問やご相談はメール | でお問い合わせください | 2.325367 | 18 |
| email | questions | 2.25418 | 24 |
| gene | library | 2.220335 | 13 |
| autoimmune | cancer | 2.19606 | 12 |
| exhibit | significantly | 2.19606 | 12 |
| antiviral | effects | 2.160239 | 28 |
| have | questions | 2.14323 | 36 |
| half | prolonged | 2.123815 | 18 |
| platform | proprietary | 2.112281 | 22 |
| cellular | immunity | 2.088586 | 15 |
| cancer | infections | 2.051473 | 12 |
| more | times | 2.039407 | 9 |
| タンパク質医薬品の生産プロセスの確立 | 研究開発 | 2.019222 | 8 |
| 北京 | 香港 | 2.019222 | 8 |
| EMA | Qualified | 2.019222 | 8 |
| Person | Qualified | 2.019222 | 8 |